Jump to content

Cytokinetics: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

10 September 2024

12 April 2024

20 March 2024

17 March 2024

29 February 2024

29 December 2023

27 December 2023

9 November 2023

16 October 2023

21 December 2022

21 August 2022

24 July 2022

18 May 2022

12 February 2022

4 January 2022

14 December 2021

8 December 2021

2 December 2021

1 December 2021

29 November 2021

2 September 2021

  • curprev 12:1412:14, 2 September 2021 Citation bot talk contribs 17,168 bytes +99 Alter: title, date, template type. Add: pmid, title, authors 1-1. Changed bare reference to CS1/2. Removed parameters. Some additions/deletions were parameter name changes. | Use this bot. Report bugs. | Suggested by BrownHairedGirl | Linked from User:BrownHairedGirl/Articles_with_bare_links | #UCB_webform_linked 1550/2177 undo

24 April 2021

23 April 2021

13 April 2021

9 April 2021

28 March 2021

12 March 2021

29 January 2021

20 January 2021

30 December 2020

19 November 2020

6 November 2020

28 October 2020

22 October 2020

  • curprev 20:2220:22, 22 October 2020 73.140.60.50 talk 14,916 bytes +694 In July 2020, Ji Xing Pharmaceuticals signed a financing deal with Cytokinetics which included the rights to commercialize the drug in China (https://endpts.com/cytokinetics-nabs-chinese-partner-up-to-450m-as-cv-becomes-company-focus/) and rounded out the other drugs in development undo Tag: Visual edit

13 October 2020

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)